In recent years, orthopaedic surgeons have attempted to decrease opioid consumption through multimodal pain management. However, a limited effort has been made to eliminate opioids entirely in the perioperative period…
The FDA has accepted an investigational new drug application for ALLO-329, an allogeneic chimeric antigen receptor T-cell therapy that may bypass lymphodepletion, paving the way…
the risk of progression and the need for surgery, with an inversely proportional relationship to the number of hours worn. However, therapeutic adherence and its…
t pain, including pain severity, interference with daily activities, and medication use (these pain dimension questions were not administered in all countries). Our analytical sample…
pecial small fiber neurophysiology such as C-fiber microneurography. Microneurography in particular has shown increased spontaneous activity, mechanosensitivity, and enhanced activity-induced slowing in C fibers of…
using a random-effects model to generate pooled estimates for overall response, complete remission, partial response, and adverse events, with subgroup analyses by myositis type and…
📢 EULAR proudly launches EULAR Rheumatology Open (ERO), a new open-access journal hosted by Elsevier, dedicated to advancing global rheumatology research. …
We’re delighted to host once again the ISEH Learning: Breathing to Win, which will take place on Friday 4th April at the Instit…
For EULAR, it is essential that the dissemination of the lay versions of the recommendations reach patient organisations, as well as healthcare professionals to support…
Predicting whether patients will achieve minimal clinically important differences following hip or knee arthroplasty
